Inhibition of malignant glioma cell growth by a survivin mutant retrovirus

Human Gene Therapy

Volumn 16, Issue 2, 2005, Pages 209-222

  Temme, A ^a   Herzig, E ^a   Weigle, B ^a   Morgenroth, A ^a   Schmitz, M ^a   Kiessling, A ^a   Rieger, M A ^a   Schackert, H K ^b   Rieber, E P ^a  

^a DRESDEN UNIVERSITY OF TECHNOLOGY   (Germany)

^b UNIVERSITY HOSPITAL CARL GUSTAV CARUS   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ALANINE; APOPTOSIS INDUCING FACTOR; BENZYLOXYCARBONYLVALYLALANYLASPARTYL FLUOROMETHYL KETONE; DNA; RETROVIRUS VECTOR; SURVIVIN; THREONINE;

AMINO ACID SUBSTITUTION; ARTICLE; CANCER CELL CULTURE; CANCER CHEMOTHERAPY; CANCER INHIBITION; CANCER RADIOTHERAPY; CANCER SURVIVAL; CELL PROLIFERATION; CONTROLLED STUDY; DIPLOIDY; DNA CONTENT; GENE OVEREXPRESSION; GLIOBLASTOMA; HUMAN; HUMAN CELL; MULTINUCLEAR CELL; RETROVIRUS; SIGNAL TRANSDUCTION; VIRUS MUTANT; VIRUS PARTICLE;

APOPTOSIS; APOPTOSIS INDUCING FACTOR; CASPASES; CELL PROLIFERATION; ENZYME INHIBITORS; FIBROBLASTS; FLAVOPROTEINS; GENE EXPRESSION; GENETIC VECTORS; GLIOMA; GREEN FLUORESCENT PROTEINS; HUMANS; LUNG; MEMBRANE PROTEINS; MICROTUBULE-ASSOCIATED PROTEINS; MUTATION; NEOPLASM PROTEINS; PROTEIN TRANSPORT; RETROVIRIDAE; TRANSFECTION;

UNIDENTIFIED RETROVIRUS;

EID: 14844311214     PISSN: 10430342     EISSN: None     Source Type: Journal    
DOI: 10.1089/hum.2005.16.209     Document Type: Article

References (46)

1. AMBROSINI, G., ADIDA, C., and ALTIERI, D.C. (1997). A novel anti-apoptosis gene, survivin, expressed in cancer and lymphoma. Nat. Med. 3, 917-921.
2. ASAI, A., MIYAGI, Y., SUGIYAMA, A., GAMANUMA, M., HONG, S.H., TAKAMOTO, S., NOMURA, K., MATSUTANI, M., TAKAKURA, K., and KUCHINO, Y. (1994). Negative effects of wild-type p53 and s-Myc on cellular growth and tumorigenicity of glioma cells: Implication of the tumor suppressor genes for gene therapy. J. Neurooncol. 19, 259-268.
3. BLANC-BRUDE, O.P., MESRI, M., WALLL, N.R., PLESCIA, J., DOHI, T., and ALTIERI, D.C. (2003). Therapeutic targeting of the survivin pathway in cancer: Initiation of mitochondrial apoptosis and suppression of tumor-associated angiogenesis. Clin. Cancer Res. 9, 2683-2692.
4. BOLTON, M.A, LAN, W., POWERS, S.E., MCCLELAND, M.L., KUANG, J., and STUKENBERG, P.T. (2002). Aurora B kinase exists in a complex with survivin and INCENP and its kinase activity is stimulated by survivin binding and phosphorylation. Mol. Biol. Cell 13, 3064-3077.
5. CANDÉ, C., CECCONI, F., DESSEN, P., and KROEMER, G. (2002). Apoptosis-inducing factor (AIF): Key to the conserved caspase-independent pathways of cell death? J. Cell Sci. 115, 4727-4234.
6. CHAKRAVARTI, A., NOLL, E., BLACK, P.M., FINKELSTEIN, D.F., FINKELSTEIN, D.M., and DYSON, N.J. (2002). Quantitatively determined survivin expression levels are of prognostic value in human gliomas. J. Clin. Oncol. 20, 1063-1068.
7. CHAKRAVARTI, A., ZHAI, G.G., ZHANG, M., MALHOTRA, R., LATHAM, D.E., DELANEY, M.A., ROBE, P., NESTLER, U., SONG, Q., and LOEFFLER, J. (2004). Survivin enhances radiation resistance in primary human glioblastoma cells via caspase-independent mechanisms. Oncogene 23, 7494-7506.
8. CHEN, J., JIN, S., TAHIR, S.K., ZHANG, H., LIU, X., SARTHY, A.V., MCGONIGAL, T.P., LIU. Z., ROSENBERG, S.H., and NG, S.C. (2003). Survivin enhances Aurora-B kinase activity and localizes Aurora-B in human cells. J. Biol. Chem. 278, 486-490.
9. CHOI, K.S., LEE, T.H., and JUNG, M.H. (2003). Ribozyme mediated cleavage of the human surviving mRNA and inhibition of antiapoptotic function of survivin in MCF-7 cells. Cancer Gene Ther. 10, 87-95.
10. CROOK, N.B., CLEM, R.J., and MILLER, L.K. (1993). An apoptosis-inhibiting baculovirus gene with a zinc finger-like motif. J. Virol. 67, 2168-2174.
11. DAS, A., TAN, W.L., TEO, J., and SMITH, D.R. (2002). Expression of survivin in primary glioblastomas. J. Cancer Clin. Oncol. 128, 302-306.
12. DAUGAS, E., SUSIN, S.A., ZAMZAMI, N., FERRI, K.F., IRINOPOULOU, T., LAROCHETTE, N., PREVOST, M.C., LEBER, B., ANDREWS, D., PENNINGRER, J., and KROEMER, G. (2000). Mitochondrio-nuciear translocation of AIF in apoptosis and necrosis. FASEB J. 14, 729-739.
13. DEGUCHI, M., SHIRAKI, K., INOUE, H., OKANO, H., ITO, T., YAMANAKA, T., SUGIMOTO, K., SAKAI, T., OHMORI, S., MURATA, K., FURUSAKA, A., HISATOMI, H., and NAKANO, T. (2002). Expression of survivin during liver regeneration Biochem. Biophys. Res. Commun. 297, 59-64.
14. FRASER, A.C., JAMES, C., EVAN, G.I., and HENGARTNER, M.O. (1999). Caenorhabditis elegans inhibitor of apoptosis protein (IAP) homologue BIR-1 plays a conserved role in cytokinesis. Curr. Biol. 9, 292-301.
15. + cells by hematopoietic growth factors: Implication of survivin expression in normal hematopoiesis. Blood 98, 2091-2100.
16. + cells and modulates cell cycle and proliferation of mouse hematopoietic progenitor cells. Blood 100, 2463-2471.
17. FUKUDA, S., MANTEL, C.R., and PELUS, L.M. (2004). Survivin regulates hematopoietic progenitor cell proliferation through p21WAF1/Cip1-dependent and -independent pathways. Blood 103, 120-127.
18. GROSSMAN, D., KIM, P.J., BLANC-BRUDE, O.P., BRASH, D.E., TOGNIN, S., MARCHISIO, P.C., and ALTIERI, D.C. (2001). Transgenic expression of survivin in keratinocytes counteracts UVB-induced apoptosis and cooperates with loss of p53. J. Clin. Invest. 108, 991-999.
19. HUFFMAN, W.H., BIADE, S., ZILFOU, J.T., CHEN, J., and MURPHY, M. (2002). Transcriptional repression of the anti-apoptotic survivin gene by wild type p53. J. Biol. Chem. 277, 3247-3257.
20. KAJIWARA, Y., YAMASAKI, F., HAMA, S., YAHARA, K., YOSHIHOKA, H., SUGIYAMA, K., ARITA, K., and KURUSI, K. (2003). Expression of survivin in astrocytic tumors: Correlation with malignant grade and prognosis. Cancer 97, 1077-1083.
21. KITAMURA, Y., OTA, T., MATSUOKA, Y., TOOYAMA, I., KIMUAR, H., SHIMOHAMA, S., NOMURA, Y., GEBICKE-HAERTER, P.J., and TANIGUCHI, T. (1999). Hydrogen peroxide-induced apoptosis mediated by p53 protein in glia1 cells. Glia 25, 154-164.
22. KONNO, R. YAMAKAWA, H., UTSUNOMIYA, H., ITO, K., SATO, S., and YAJIMA, A. (2000). Expression of survivin and Bcl-2 in the normal human endometrium. Mol. Hum. Reprod. 6, 529-534.
23. KREX, D., MOHR, B., HAUSES, M., EHNINGER, G., SCHACKERT, H.K., and SCHACKERT, G. (2001). Identification of uncommon chromosomal aberrations in the neuroglioma cell line H4 by spectral karyotyping. J. Neurooncol. 52, 119-128.
24. LAEMMLI, U.K. (1970). Cleavage of structural proteins during assembly of the head of bacteriophage T4. Nature 227, 680-686.
25. LI, F., AMBROSINI, G., CHU, E.Y., PLESCIA, J., TOGNIN, S., MARCHISIO, P.C., and ALTIERI, D.C. (1998). Control of apoptosis and mitotic spindle checkpoint by survivin. Nature 396, 580-584.
26. LIU, T., BROUHA, B., and GROSSMAN, D. (2004). Rapid induction of mitochondrial events and caspase-independent apoptosis in survivin-targeted melanoma cells. Oncogene 23, 39-48.
27. MAYO, L.D., DIXON, J.E., DURDEN, D.L., TONKS, N.K., and DONNER, D.B. (2002). PTEN protects p53 from Mdm2 and sensitizes cancer cells to chemotherapy. J. Biol. Chem. 277, 5484-5489.
28. MESRI, M., WALL, R.W., LI, J., KIM, R.W., and ALTIERI, D.C. (2001). Cancer gene therapy using a survivin mutant adenovirus. J. Clin. Invest. 108, 981-990.
29. MIRZA, A., MCGUIRK, M., HOCKENBERRY, T.N., WU, Q., ASHAR, H., BLACK, S, WEN, S.F., WANG, L., KIRSCHMEIER, P., BISHOP, W.R., NIELSEN, L.L., PICKETT, C.B., and LIU, S. (2002). Human survivin is negatively regulated by wild-type p53 and participates in p53-dependent apoptotic pathway. Oncogene 21, 2613-2622.
30. O'CONNOR, D.S., GROSSMAN, D., PLESCIA, J., LI, F., ZHANG, H., VILLA, A., TOGNIN, S., MARCHISIO, P.C., and ALTIERI, D.C. (2000). Regulation of apoptosis at cell division by p34cdc2 phosphorylation of survivin. Proc. Natl. Acad. Sci. U.S.A. 97, 13103-13107.
31. OTA, T., SUTO, S., KATAYAMA, H., HAN, Z.B., SUZUKI, F., MAEDA, M., TANINO, M., TERADA, Y., and TATSUKA, M. (2002). Increased mitotic phosphorylation of histone H3 attributable to AIM-1/Aurora-B overexpression contributes to chromosome number instability. Cancer Res. 62, 5168-5177.
32. REED, J.C. (2001). The survivin saga goes in vivo. J. Clin. Invest. 108, 965-969.
33. SHANKAR, S.L., MANI, S., O'GUIN, K.N., KANDIMALLLA, E.R., AGRAWAL, S., and SHAFIT-ZAGARDO, B. (2001). Survivin inhibition induces human neural tumor cell death through caspase-independent and -dependent pathways. J. Neurochem. 79, 426-436.
34. SHEN, C., BUCK, A., POLAT, B., SCHMID-KOTSAS, A., MAUSCHEK, C., GROSS, H.J., and BACHEM, M. (2003). Triplex-forming oligodeoxynucleotides targeting survivin inhibit proliferation and induce apoptosis of human lung carcinoma cells. Cancer Gene Ther. 10, 403-407.
35. SHONO, T., TOFILON, P.J., SCHAEFER, T.S., PARIKH, D., LIU, T.J., and LANG, F.F. (2002). Apoptosis induced by adenovirus-mediated p53 gene transfer in human glioma correlates with site-specific phosphorylation. Cancer Res. 62, 1069-1076.
36. SILKE, J., and VAUX, D.L. (2001). Two kinds of BIR-containing protein: Inhibitors of apoptosis, or required for mitosis. J. Cell Sci. 114, 1821-1827.
37. SKOUFIAS, D.A., MOLLINARI, C., LACROIX, F.B., and MARGOLIS, R.L. (2000). Human survivin is a kinetochore-associated passenger protein. J. Cell Biol. 25, 1575-1582.
38. SONEOKA, Y., CANNON, P.M., RAMSDALE, E.E., GRIFFITHS, J.C., ROMANO, G., KINGSMAN, S.M., and KINGSMAN, A.J. (1995). A transient three-plasmid expression system for the production of high titer retroviral vectors. Nucleic Acids Res. 23, 628-633.
39. SPELIOTES, E.K., UREN, A., VAUX, D., and HORVITZ, H.R. (2000). The survivin-like C. elegans BIR-1 protein acts with the Aurora-like kinase AIR-2 to affect chromosomes and the spindle midzone. Mol. Cell 6, 211-223.
40. + cord blood-derived dendritic cells. Gene Ther. 9, 1551-1560.
41. TEMME. A., RIEGER, M., REBER, F., LINDEMANN, D., WEIGLE, B., DIESTELKOETTER-BACHERT, P., EHNINGER, G., TATSUKA, M., TERADA, Y., and RIEBER, E.P. (2003). Localization, dynamics, and function of survivin revealed by expression of functional survivinDsRed fusion proteins in the living cell. Mol. Biol. Cell 14, 78-92.
42. TATSUKA, M., KATAYAMA, H., OTA, T., TANAKA, T., ODASHIMA, S., SUZUKI, F., and TERADA, Y. (1998). Multinuclearity and increased ploidy caused by overexpression of the aurora- and Ip11-like midbody-associated protein mitotic kinase in human cancer cells. Cancer Res. 58, 4811-4816.
43. UREN, A.C., WONG, L., PAKUSCH, M., FOWLER, K.J., BURROWS, F.J., VAUX, D.L., and CHOO, K.H. (2000). Survivin and the inner centromere protein INCENP show similar cell-cycle localization and gene knockout phenotype. Curr. Biol. 10, 1319-1328.
44. VELCULESCU, V.E., MADDEN, S.L., ZHANG, L., LASH, A.E., YU, J., RAGO, C., LAL, A., WANG, C.J., BEAUDRY, G.A., CIRIELLO, K.M., COOK, B.P., DUFAULT, M.R., FERGUSON, AT., GAO, Y., HE, T.C., HERMEKING, H., HIRALDO, S.K., HWANG, P.M., LOPEZ, M.A., LUDERER, H.F., MATHEWS, B., PETROZIELLLO, J.M., POLYAK, K., ZAWEL, L., KINZLER, K.W., et al. (1999). Analysis of human transcriptomes. Nat. Genet. 23, 387-388.
45. WHEATLEY, S.P., CARVALHO, A., VAGNARELLII, P., and EARNSHAW, W.C. (2001). INCENP is required for proper targeting of survivin to the centromeres and the anaphase spindle during mitosis. Curr. Biol. 11, 886-890.
46. ZHOU, H., KUANG, J., ZHONG, L., KUO, W.L., GRAY, J.W., SAHIN, A., BRINKLEY, B.R., and SEN, S. (1998). Tumor amplified kinase STK15/BTAK induces centrosome amplification, aneuploidy and transformation. Nat. Genet. 20, 189-193.